Back to Journals » Neuropsychiatric Disease and Treatment

Neuropsychiatric Disease and Treatment

COPE logo
ISSN: 1178-2021

Journal Articles:

- 4,657 records -

Clinical Benefit and Risk Profile of TV-46000 for Patients with Schizophrenia as Assessed by Number Needed to Treat and Number Needed to Harm

Citrome L, Franzenburg KR, Suett M, Tohami O, Sharon N, Jehassi A, Harary E, Yu D, Correll CU

Neuropsychiatric Disease and Treatment 2026, 22:534730

Published Date: 8 May 2026

Efficacy and Safety of Escitalopram for Major Depressive Disorder in Children and Adolescents: A Systematic Review and Meta-Analysis with Age-Specific Findings

Maneeton B, Maneeton N, Pojanapotha P, Putthisri S, Oon-arom A, Karawekpanyawong N, Kawilapat S, Maneeton P, Srichan K

Neuropsychiatric Disease and Treatment 2026, 22:595606

Published Date: 5 May 2026

Peripheral Blood Regulatory T Cells and IL-6 are Associated with Cognitive Impairment After Acute Ischemic Stroke

Chang Y, Zhang X, Yu C, Zhu L, Sun S, Sun Z

Neuropsychiatric Disease and Treatment 2026, 22:590109

Published Date: 1 May 2026

Optimizing Identification and Management of Depression in Neurological Diseases: A Narrative Review and Expert Perspective

Bartova L, Beuster ML, Bonetti B, Maina G, Morgado P, Nyberg J

Neuropsychiatric Disease and Treatment 2026, 22:575685

Published Date: 1 May 2026

Association Between Frontotemporal Atrophy and Cognitive Impairment in Patients with Schizophrenia Based on Computed Tomography Imaging

Wang Y, Yang J, Ye Y, Lu L, Wang H, Guo P, Hou N, Huang X, Li C

Neuropsychiatric Disease and Treatment 2026, 22:602462

Published Date: 30 April 2026

Long-Term Effectiveness and Safety of LCIG in Romania. 3-year Results from a Prospective, Observational Study (DUOGLOBE)

Szasz JA, Constantin VA, Jianu DC, Dan TF, Dulamea AO, Sabau M, Vasile MT, Bergmann L, Popescu D, Simu MA

Neuropsychiatric Disease and Treatment 2026, 22:564900

Published Date: 28 April 2026

An Open-Label, Single-Arm Trial of Transcranial and Intranasal Photobiomodulation in Patients with Schizophrenia: A Study Protocol

Yamada R, Izumi S, Oba MS, Noda T, Stickley A, Sumiyoshi T

Neuropsychiatric Disease and Treatment 2026, 22:585770

Published Date: 21 April 2026

Neurocognitive and Psychiatric Outcomes Following Mild to Moderate COVID-19: A Longitudinal Comparison of Alpha/Delta and Omicron Variants

Lynch ST, Dornbush R, Aftab S, Mansour R, Libretti A, Shahar S, Bilal A, Klepacz L, Ferrando SJ

Neuropsychiatric Disease and Treatment 2026, 22:594322

Published Date: 18 April 2026

Wavelet Entropy Analysis of EEG Signals During Wake and Sleep in Patients with Alzheimer’s Disease: A Pilot Study

Tong Y, Hu G, Liu L, Zhang Y, Jiang N, Zhang M

Neuropsychiatric Disease and Treatment 2026, 22:585445

Published Date: 15 April 2026

Influence of Neuraxial Anesthesia Technique During Vaginal and Cesarean Delivery and Association with Postpartum Depression: A Narrative Review of Literature

Fagan JJ, Dufour SI, Duet SJ, Downs EM, Siddaiah H, Viswanath O, Shekoohi S, Kaye AD

Neuropsychiatric Disease and Treatment 2026, 22:579920

Published Date: 14 April 2026

Associations of Perceived Parenting Practices with Mother–Infant Bonding at 1-Month Postpartum via Adult Attachment, Depression, and Anxiety in Japanese Mothers

Por L, Zain E, Fukui N, Watanabe Y, Hashijiri K, Motegi T, Ogawa M, Boku S

Neuropsychiatric Disease and Treatment 2026, 22:595969

Published Date: 8 April 2026

Correlates of Anti-Toxoplasma IgG Antibodies in Females with Borderline Personality Disorder: A Pilot Cross-Sectional Study

Ociskova M, Prasko J, Belohradova K, Visnovsky J, Vanek J, Genzor S, Sauer P, Latalova K

Neuropsychiatric Disease and Treatment 2026, 22:593736

Published Date: 3 April 2026

The Influence of Lifestyle on Cognitive Function and Quality of Life in People with Dementia

Lu H, Rao X, Li N, Liu X, Peng L, Yang B, Liao Q, Lai X

Neuropsychiatric Disease and Treatment 2026, 22:565372

Published Date: 3 April 2026

Efficacy and Clinical Relevance of Adjunctive Cariprazine Treatment in Patients with Major Depressive Disorder: Post Hoc Analyses from a Phase III Study

Papakostas GI, Masand PS, Clayton AH, Maletic V, Adams JL, Rekeda L, Singh MK, Kerolous M

Neuropsychiatric Disease and Treatment 2026, 22:561112

Published Date: 1 April 2026

Imbalance of the Brain–Gut–Microbiota Axis in Major Depressive Disorder: From Pathogenesis to Clinical Translation

Wu T, Xing H, Wu T, Xie X, Ji L, Wang W, Zhang X, Zhang Y, Jiang C, Bao T

Neuropsychiatric Disease and Treatment 2026, 22:591429

Published Date: 30 March 2026

The Effect of Sandplay Therapy on Children with Autism Spectrum Disorder: A Systematic Review and Meta-Analysis

Wu X, Zhao X, Meng Y, Huang L, Xie L, Huang S, Yang J, Song Y

Neuropsychiatric Disease and Treatment 2026, 22:579433

Published Date: 26 March 2026

Morphometric Similarity Loss and Gray Matter Atrophy Align with Neurotransmitter and Mitochondrial Maps in Drug-Resistant Epilepsy

Zhao J, Gao M, Zhou L, Wan S, Liao N, Yu S, Chen X, Shu H

Neuropsychiatric Disease and Treatment 2026, 22:582833

Published Date: 24 March 2026

The Use of Vagus Nerve Stimulation (VNS) in the Management of Patients with Difficult-to-Treat Major Depressive Disorder (MDD): An Expert Consensus Statement

McAllister-Williams RH, Alva G, Banov M, Conway CR, Cusin C, De Beer JC, Demyttenaere K, Domany Y, Domenech P, Dougherty DD, Dunner DL, Feffer K, George MS, Iosifescu DV, Kavakbasi E, Kraus C, Lehnhardt FG, Lesperance P, McCall WV, Murrough JW, Nahas Z, Nemeroff CB, Quevedo J, Reif-Leonhard C, Riva-Posse P, Rush AJ, Schwartz TL, Stander MP, Williams NR, Zajecka J, Aaronson ST, Baune BT, Sackeim HA

Neuropsychiatric Disease and Treatment 2026, 22:554007

Published Date: 18 March 2026

Psychiatric Comorbidity in Chronic Tinnitus: Depression and Anxiety in an Otolaryngology Outpatient Cohort

Sırma E, Dedeoglu S, Toprak SF, Dönmezdil S

Neuropsychiatric Disease and Treatment 2026, 22:589644

Published Date: 18 March 2026

Threshold Effect of Anxiety in the Comorbidity of Depression and Chronic Pain: A Cross-Sectional Study Based on Pain Sensitivity

Liu Y, Cheng J, Gao H, Chen Y, Chen H, Xia Q, Yan J, Li C, Ju P, Zhu C

Neuropsychiatric Disease and Treatment 2026, 22:580711

Published Date: 17 March 2026

Lurasidone in Schizophrenia Management: A Comprehensive 12-Week Post-Marketing Surveillance Study in Chinese Patients

Wei YM, Yang XD, Wang CS, Wang LL, Deng HL, Sang H, Xue AL, Zhu DM, Li-YM, Liu XJ, Li H, Shen YF

Neuropsychiatric Disease and Treatment 2026, 22:588526

Published Date: 12 March 2026

Parameter-Specific Effects of Low-Intensity Transcranial Focused Ultrasound Stimulation on Depression-Like Behaviors in a CUMS Mouse Model

Zhang Y, Zhang Y, Zhang K, Wang L, Huang D, Zhen F, Wang R, An C

Neuropsychiatric Disease and Treatment 2026, 22:586583

Published Date: 12 March 2026

More articles